These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19409928)

  • 1. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.
    Varga Z; Csepany T; Papp F; Fabian A; Gogolak P; Toth A; Panyi G
    Immunol Lett; 2009 Jun; 124(2):95-101. PubMed ID: 19409928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
    Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium channels as therapeutic targets for autoimmune disorders.
    Wulff H; Beeton C; Chandy KG
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-tuning of regulatory T cell function: the role of calcium signals and naive regulatory T cells for regulatory T cell deficiency in multiple sclerosis.
    Schwarz A; Schumacher M; Pfaff D; Schumacher K; Jarius S; Balint B; Wiendl H; Haas J; Wildemann B
    J Immunol; 2013 May; 190(10):4965-70. PubMed ID: 23576680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of K2P5.1 potassium channels in multiple sclerosis.
    Bittner S; Bobak N; Herrmann AM; Göbel K; Meuth P; Höhn KG; Stenner MP; Budde T; Wiendl H; Meuth SG
    Ann Neurol; 2010 Jul; 68(1):58-69. PubMed ID: 20582984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse.
    Aristimuño C; Navarro J; de Andrés C; Martínez-Ginés L; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
    J Neuroimmunol; 2008 Nov; 204(1-2):131-5. PubMed ID: 18835045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
    Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
    Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental switch of the expression of ion channels in human dendritic cells.
    Zsiros E; Kis-Toth K; Hajdu P; Gaspar R; Bielanska J; Felipe A; Rajnavolgyi E; Panyi G
    J Immunol; 2009 Oct; 183(7):4483-92. PubMed ID: 19748986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.
    Wulff H; Calabresi PA; Allie R; Yun S; Pennington M; Beeton C; Chandy KG
    J Clin Invest; 2003 Jun; 111(11):1703-13. PubMed ID: 12782673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion channels in T cells: from molecular pharmacology to therapy.
    Krasznai Z
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):127-35. PubMed ID: 15928581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
    Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
    Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbed regulatory T cell homeostasis in multiple sclerosis.
    Venken K; Hellings N; Liblau R; Stinissen P
    Trends Mol Med; 2010 Feb; 16(2):58-68. PubMed ID: 20159585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells in Graves' disease.
    Pan D; Shin YH; Gopalakrishnan G; Hennessey J; De Groot LJ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):587-93. PubMed ID: 19222488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
    Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
    Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
    Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
    Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2.
    Pedersen AE; Lauritsen JP
    Scand J Immunol; 2009 Jul; 70(1):40-3. PubMed ID: 19522766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.